The Ajax armoured vehicle programme, valued at £6.3 billion, will proceed with resumed trials following a comprehensive investigation into soldier illness reports. Defence officials determined that environmental factors, particularly cold weather exposure, rather than equipment defects, caused the health concerns among military personnel. The decision allows the procurement initiative to move forward despite previous setbacks and public concerns about the vehicles' development and safety protocols.

Summary auto-generated by AI from the original publisher's content. Editorial standards.